Projects per year
Personal profile
Personal profile
Tetsuo Ashizawa, MD, formerly the executive director of the McKnight Brain Institute at the University of Florida, organized and developed interdisciplinary neuroscience research programs involving multiple colleges and departments. He also chaired the neurology department at the University of Texas Medical Branch and at the University of Florida, where he supervised the clinical care of and research in a variety of neurological disorders.
As a physician-scientist, some of Dr. Ashizawa’s current research is funded by the National Institutes of Health, the Muscular Dystrophy Association and the Myotonic Dystrophy Foundation. He is studying neurogenetic disorders caused by expansions of DNA sequences that are connected end-to-end and abnormally repeated, such as myotonic dystrophies, spinocerebellar ataxias, Friedreich’s ataxia, and Huntington’s disease.
Dr. Ashizawa received his medical degree from the Keio University School of Medicine in Tokyo. After moving to the U.S., he completed his neurology residency and Muscular Dystrophy Association fellowships in neurochemistry and clinical neuromuscular disorders at Baylor College of Medicine.
Dr. Ashizawa is board certified in neurology by the American Board of Psychiatry and Neurology. He serves on multiple grant review panels, including NIH study sections, and on the scientific advisory boards of the Myotonic Dystrophy Foundation, the National Ataxia Foundation, and the Association Française contre les Myopathies.
Education/Academic qualification
Neuromuscular Disorders, Fellow, Baylor College of Medicine
1978 → 1979
Neurology, Residency, Baylor College of Medicine
1975 → 1978
Medicine, MD, Keio University School of Medicine
1969 → 1973
Research Area Keywords
- Neurosciences
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
Ashizawa, T. (PI)
3/1/23 → 6/30/26
Project: Federal Funding Agencies
-
Myotonic Dystrophy Compilation of Clinical Findings
Greene, E. P. (PI), Appel, S. H. (Key Personnel), Ashizawa, T. (Key Personnel), Mathuria, N. (Key Personnel) & Shroff, S. (Key Personnel)
4/1/20 → …
Project: Clinical Trial
-
National Ataxia Foundation (NAF) - Clinical Research Consortium for the Study of Cerebellar Ataxias
Ashizawa, T. (PI) & Billnitzer, A. (PI)
6/16/17 → 12/31/25
Project: Non Profit
-
Supplementary funding for U01NS104326 Clinical Trial Readiness for SCA1 and SCA3 (?READISCA?)
Ashizawa, T. (PI)
6/1/22 → 12/31/23
Project: Federal Funding Agencies
-
Understanding the long term impact of COVID-19 on the brain through advanced MR imaging and spectroscopy
Ashizawa, T. (PI) & Karmonik, C. (Key Personnel)
7/15/21 → 6/30/24
Project: Federal Funding Agencies
-
ATXN10 Gene Expansions in Mexican Patients with Ataxia Without Epilepsy
Jara-Prado, A., Arias-Capistran, E., Guerrero-Camacho, J., Ochoa-Morales, A., Boll, M. C., Dávila-Ortíz de Montellano, D., Rasmussen, A., Ashizawa, T., Fernandez-Ruiz, J., Yescas-Gómez, P. & Ramírez-García, M. Á., Jan 16 2025, In: Cerebellum. 24, 2, p. 33 33.Research output: Contribution to journal › Article › peer-review
-
Emerging therapies in hereditary ataxias
Eisel, M. L. S., Burns, M., Ashizawa, T., Byrne, B., Corti, M. & Subramony, S. H., Feb 2025, In: Trends in Molecular Medicine. 31, 2, p. 181-194 14 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
The impact of interrupted ATXN10 expansions on clinical findings of spinocerebellar ataxia type 10
Hasan, A., Furtado, G. V., Miglorini, E., Mergener, R., Massuyama, B., Barsottini, O., Pedroso, J. L., Teive, H. G., Saraiva-Pereira, M. L., Ashizawa, T. & Jardim, L. B., Apr 2025, In: Journal of Neurology. 272, 4, p. 261 261.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Extended haplotype with rs41524547-G defines the ancestral origin of SCA10
McFarland, K. N., Tiwari, A., Hashem, V., Zhang, L., Zeng, D., Vincent, J., Arredondo, M. J., Johnson, K. L., Gan, S. R., Yabe, I., Skov, L., Rasmussen, A. & Ashizawa, T., Sep 15 2024, In: Human Molecular Genetics. 33, 18, p. 1567-1574 8 p., ddae092.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias
Lai, R. Y., Rummey, C., Amlang, C. J., Lin, C. Y. R., Chen, T. X., Perlman, S., Wilmot, G., Gomez, C. M., Schmahmann, J. D., Paulson, H., Ying, S. H., Onyike, C. U., Zesiewicz, T. A., Bushara, K. O., Geschwind, M. D., Figueroa, K. P., Pulst, S. M., Subramony, S. H., Burns, M. R. & Opal, P. & 9 others, , May 2024, In: Movement Disorders Clinical Practice. 11, 5, p. 496-503 8 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Prizes
-
DNAzymes for cleaving CAG repeat RNA and eliminating viral RNA
Zhang, N. (Recipient) & Ashizawa, T. (Recipient), Nov 11 2020
Prize: Prize (including medals and awards)